Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-506 Monotherapy or Combination in Advanced Solid Tumors
NCT04954599Phase 2Recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- May 2023
- Primary completion
- Feb 2027
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 3
01
Overview
A Phase 2 trial of cp-506 in solid tumor, sponsored by Maastricht University Medical Center+. Started May 2023; status: recruiting.
02
Drugs
cp-506
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04954599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04954599.